We recently published 12 Best Healthcare Stocks to Buy Under $30. MannKind Corporation (NASDAQ:MNKD) is one of the best ...

MannKind (NASDAQ:MNKD), a biopharmaceutical firm known for its inhaled insulin and pulmonary therapeutics, released its second quarter 2025 earnings on August 6, 2025. The most si ...

The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...

MannKind Corporation (NASDAQ:MNKD) presented inhaled insulin therapy at the American Diabetes Association’s 85th Scientific Sessions in Chicago, which was held from June 20 to June 23, 2025.

Ultra-rapid insulins are used to manage type 1 and type 2 diabetes. Learn about the different types, their effectiveness, and how they can provide mealtime flexibility.

The doll pairs a blue polka-dot outfit with an insulin pump and continuous glucose monitor.

The global health landscape is evolving with Brazil battling bird flu-related trade restrictions, Nestle USA eliminating synthetic food colors by 2026, and Novo Nordisk launching a weight-loss drug in ...

Recent advancements in inhaled insulin for type 1 diabetes and once-weekly insulin for type 2 diabetes present promising alternatives to injections. Additionally, genetically engineered skin grafts ...